Skip to main content

Stable Angina

2
Pipeline Programs
10
Companies
10
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

B. Braun
B. BraunGermany - Melsungen
2 programs
2
3-months DAPTPhase 41 trial
FFR - guided DEB angioplastyPhase 41 trial
Active Trials
NCT02601157Completed2,173Est. Aug 2022
NCT02120859Completed50Est. Apr 2014
Boston Scientific
Boston ScientificCA - Valencia
2 programs
Boston Scientific Pressure WireN/A1 trial
Percutaneous Coronary InterventionN/A1 trial
Active Trials
NCT02578381Completed106Est. Nov 2016
NCT02099617Completed1,200Est. Jun 2018
OrbusNeich
OrbusNeichChina - Hong Kong
2 programs
COMBO-StentPHASE_41 trial
Endothelial cell capture stent with 1 month clopidogrelPHASE_41 trial
Active Trials
NCT02723981Withdrawn0Est. Dec 2018
NCT01394848Terminated1Est. Jan 2013
Philips
PhilipsNetherlands - Amsterdam
1 program
Instantaneous wave-free ratio measurementN/A1 trial
Active Trials
NCT03338309Active Not Recruiting1,200Est. Dec 2025
Abbott
AbbottABBOTT PARK, IL
1 program
Short DAPTN/A1 trial
Active Trials
NCT07198529Recruiting130Est. Sep 2029
Miracor Medical
Miracor MedicalBelgium - Awans
1 program
PICSOPHASE_21 trial
Active Trials
NCT01308125Completed10Est. Apr 2011
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
NicorandilPHASE_41 trial
Active Trials
NCT01396395Completed402Est. May 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
OrbusNeichCOMBO-Stent
B. Braun3-months DAPT
B. BraunFFR - guided DEB angioplasty
OrbusNeichEndothelial cell capture stent with 1 month clopidogrel
Merck & Co.Nicorandil
Miracor MedicalPICSO
AbbottShort DAPT
PhilipsInstantaneous wave-free ratio measurement
Boston ScientificBoston Scientific Pressure Wire
Boston ScientificPercutaneous Coronary Intervention

Clinical Trials (10)

Total enrollment: 5,272 patients across 10 trials

NCT02723981OrbusNeichCOMBO-Stent

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials

Start: Apr 2016Est. completion: Dec 20180
Phase 4Withdrawn
NCT02601157B. Braun3-months DAPT

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Start: Jan 2016Est. completion: Aug 20222,173 patients
Phase 4Completed
NCT02120859B. BraunFFR - guided DEB angioplasty

Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty

Start: Oct 2012Est. completion: Apr 201450 patients
Phase 4Completed
NCT01394848OrbusNeichEndothelial cell capture stent with 1 month clopidogrel

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy

Start: Oct 2011Est. completion: Jan 20131 patients
Phase 4Terminated
NCT01396395Merck & Co.Nicorandil

Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

Start: Sep 2011Est. completion: May 2014402 patients
Phase 4Completed
NCT01308125Miracor MedicalPICSO

Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention

Start: Oct 2010Est. completion: Apr 201110 patients
Phase 2Completed
NCT07198529AbbottShort DAPT

OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina

Start: Sep 2025Est. completion: Sep 2029130 patients
N/ARecruiting
NCT03338309PhilipsInstantaneous wave-free ratio measurement

INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry

Start: Nov 2017Est. completion: Dec 20251,200 patients
N/AActive Not Recruiting
NCT02578381Boston ScientificBoston Scientific Pressure Wire

Boston Scientific COMET Wire Validation Study

Start: Mar 2016Est. completion: Nov 2016106 patients
N/ACompleted
NCT02099617Boston ScientificPercutaneous Coronary Intervention

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.

Start: May 2014Est. completion: Jun 20181,200 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 5,272 patients
10 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.